Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Top Cited Papers
- 1 August 2001
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 50 (4) , 260-265
- https://doi.org/10.1016/s0006-3223(01)01083-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2000
- Region-Specific Neurotrophin Imbalances in Alzheimer DiseaseArchives of Neurology, 2000
- Hippocampal Volume Reduction in Major DepressionAmerican Journal of Psychiatry, 2000
- Administration of a cAMP Phosphodiesterase 4 Inhibitor Enhances Antidepressant-Induction of BDNF mRNA in Rat HippocampusNeuropsychopharmacology, 2000
- G Protein‐Coupled Cyclic AMP Signaling in Postmortem Brain of Subjects with Mood DisordersJournal of Neurochemistry, 1999
- Immortal Time: Circadian Clock Properties of Rat Suprachiasmatic Cell LinesScience, 1999
- Increased temporal cortex CREB concentrations and antidepressant treatment in major depressionThe Lancet, 1998
- A Molecular and Cellular Theory of DepressionArchives of General Psychiatry, 1997
- Electroconvulsive Seizure Increases the Expression of CREM (Cyclic AMP Response Element Modulator) and ICER (Inducible Cyclic AMP Early Repressor) in Rat BrainJournal of Neurochemistry, 1996
- Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victimsBrain Research, 1994